<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.00822.006</object-id><label>Table 1.</label><caption><title>Flow cytometric immunophenotyping of <italic>E&#956;-myc</italic> lymphomas with enforced expression of different <italic>mir-17-92</italic> derivatives</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00822.006">http://dx.doi.org/10.7554/eLife.00822.006</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Genotype</th><th>n</th><th>Percentage (%)</th><th>Immunotype</th></tr></thead><tbody><tr><td rowspan="2"><italic>E&#956;-myc/MSCV</italic></td><td align="char" char=".">4</td><td align="char" char=".">40</td><td>B220+, IgM&#8722;, CD19+, CD4&#8722;, CD8&#8722;</td></tr><tr><td align="char" char=".">6</td><td align="char" char=".">60</td><td>B220+, IgM+, CD19+, CD4&#8722;, CD8&#8722; <xref ref-type="table-fn" rid="tblfn1">*</xref></td></tr><tr><td rowspan="3"><italic>E&#956;-myc/17&#8211;92</italic></td><td align="char" char=".">4</td><td align="char" char=".">40</td><td>B220+, IgM&#8722;, CD19+, CD4&#8722;, CD8&#8722;</td></tr><tr><td align="char" char=".">5</td><td align="char" char=".">50</td><td>B220+, IgM+, CD19+, CD4&#8722;, CD8&#8722; <xref ref-type="table-fn" rid="tblfn2">&#8224;</xref></td></tr><tr><td align="char" char=".">1</td><td align="char" char=".">10</td><td>B220&#8722;, IgM&#8722;, CD19&#8722;, CD4+, CD8+</td></tr><tr><td rowspan="2"><italic>E&#956;-myc/17&#8211;92Mut92</italic></td><td align="char" char=".">7</td><td align="char" char=".">70</td><td>B220+, IgM&#8722;, CD19+, CD4&#8722;, CD8&#8722;</td></tr><tr><td align="char" char=".">3</td><td align="char" char=".">30</td><td>B220+, IgM+, CD19+, CD4&#8722;, CD8&#8722; <xref ref-type="table-fn" rid="tblfn3">&#8225;</xref></td></tr><tr><td rowspan="2"><italic>E&#956;-myc/1792&#916;92</italic></td><td align="char" char=".">8</td><td align="char" char=".">80</td><td>B220+, IgM&#8722;, CD19+, CD4&#8722;, CD8&#8722;</td></tr><tr><td align="char" char=".">2</td><td align="char" char=".">20</td><td>B220+, IgM+, CD19+, CD4&#8722;, CD8&#8722; <xref ref-type="table-fn" rid="tblfn4">&#167;</xref></td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>*</label><p>1 out of 6 samples predominantly contains IgM+ cells, with a small percentage of IgM&#8722; cells.</p></fn><fn id="tblfn2"><label>&#8224;</label><p>3 out of 5 samples predominantly contain IgM+ cells, with a small percentage of IgM&#8722; cells.</p></fn><fn id="tblfn3"><label>&#8225;</label><p>1 out of 3 samples predominantly contains IgM+ cells, with a small percentage of IgM&#8722; cells.</p></fn><fn id="tblfn4"><label>&#167;</label><p>1 out of 2 samples predominantly contains IgM+ cells, with a small percentage of IgM&#8722; cells.</p></fn></table-wrap-foot></table-wrap>